Gene · 442890
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Distinct microRNA signatures define sporadic PSP-RS and PD in patient-derived midbrain organoids. | iScience | 2025 | 40799390 | PubTator, text mining | PubMed |
| Bridging the gaps in detection of structural cardiotoxicity in stem cell-derived cardiomyocytes: promise of miR-133b, miR-184 and miR-208b-3p. | Front Pharmacol | 2025 | 40786048 | PubTator, text mining | PubMed |
| Cerebral ischemia-reperfusion injury: mechanisms and promising therapies. | Front Pharmacol | 2025 | 40766753 | PubTator, text mining | PubMed |
| Epigenetic Modulation and Brain Function in Parkinson's Disease: The Role of Exercise Alone or Combined With Polyphenols. | Food Sci Nutr | 2025 | 40735395 | PubTator, text mining | PubMed |
| Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment. | Biology (Basel) | 2025 | 40723400 | PubTator, text mining | PubMed |
| MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma. | Front Oncol | 2025 | 40630212 | PubTator, text mining | PubMed |
| Widespread tissue delivery of antagomiRs via intramuscular administration. | Mol Ther Methods Clin Dev | 2025 | 40519322 | PubTator, text mining | PubMed |
| Effects of Yoga on Gene Expression: A Systematic Review of Randomised Controlled Trials. | Cureus | 2025 | 40400827 | PubTator, text mining | PubMed |
| The impact of mutations on TP53 protein and MicroRNA expression in HNSCC: Novel insights for diagnostic and therapeutic strategies. | PLoS One | 2025 | 40333905 | PubTator, text mining | PubMed |
| METTL14 regulates proliferation and differentiation of duck myoblasts through targeting MiR-133b. | PLoS One | 2025 | 40153415 | PubTator, text mining | PubMed |
| A positive feedback loop between FOSB and miR-133b controls colon cancer cell proliferation. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40151144 | PubTator, text mining | PubMed |
| The potential role of RhoA/ROCK-inhibition on locomotor recovery after spinal cord injury: a systematic review of in-vivo studies. | Spinal Cord | 2025 | 39956860 | PubTator, text mining | PubMed |
| Genome-wide profiling of circulating microRNAs in adolescent idiopathic scoliosis and their relation to spinal deformity severity, and disease pathophysiology. | Sci Rep | 2025 | 39939711 | PubTator, text mining | PubMed |
| Blood exosome connexins and small RNAs related to demyelinating disease activity. | Ann Clin Transl Neurol | 2025 | 39901658 | PubTator, text mining | PubMed |
| Exploring miRNA profile associated with cisplatin resistance in ovarian cancer cells. | Biochem Biophys Rep | 2025 | 39830525 | PubTator, text mining | PubMed |
| RETRACTION: MiR-145 Promotes MiR-133b Expression Through c-myc and DNMT3A-mediated Methylation in Ovarian Cancer Cells. | J Cell Physiol | 2025 | 39806777 | PubTator, text mining | PubMed |
| Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training. | Rheumatology (Oxford) | 2025 | 39775851 | PubTator, text mining | PubMed |
| Muscle-Derived Bioactive Factors: MyoEVs and Myokines. | Cell Prolif | 2025 | 39737773 | PubTator, text mining | PubMed |
| Exploring dysregulated miRNAs in ALS: implications for disease pathogenesis and early diagnosis. | Neurol Sci | 2025 | 39570437 | PubTator, text mining | PubMed |
| Rational design of siRNA-based delivery systems for effective treatment of brain diseases. | Pharm Sci Adv | 2024 | 41550166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442890/papers?page=4